Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Ribozymes as Therapeutic Agents against Infectious Diseases

View through CrossRef
Ribozymes, also known as RNA enzymes, are catalytic RNA molecules capable of cleaving specific RNA sequences, leading to decreased expression of targeted genes. Recent studies suggest their role in cancer therapeutics, genetic diseases and retroviral infections. This book chapter will focus on ribozymes acting as therapeutic agents against infectious diseases caused by viral and bacterial pathogens. Firstly, we will introduce a brief history of ribozymes and a general overview of ribozymes and their characteristics. Next, different types of ribozymes will be explored regarding their targets and mechanisms of action. After that, ribozymes specific to viral and bacterial infections will be explored. We will briefly discuss the current status of ribozymes as therapeutic agents. Finally, the roadblock and challenges ribozymes face before being developed into therapeutic agents—such as their delivery and efficacy issues—will be discussed.
Title: Ribozymes as Therapeutic Agents against Infectious Diseases
Description:
Ribozymes, also known as RNA enzymes, are catalytic RNA molecules capable of cleaving specific RNA sequences, leading to decreased expression of targeted genes.
Recent studies suggest their role in cancer therapeutics, genetic diseases and retroviral infections.
This book chapter will focus on ribozymes acting as therapeutic agents against infectious diseases caused by viral and bacterial pathogens.
Firstly, we will introduce a brief history of ribozymes and a general overview of ribozymes and their characteristics.
Next, different types of ribozymes will be explored regarding their targets and mechanisms of action.
After that, ribozymes specific to viral and bacterial infections will be explored.
We will briefly discuss the current status of ribozymes as therapeutic agents.
Finally, the roadblock and challenges ribozymes face before being developed into therapeutic agents—such as their delivery and efficacy issues—will be discussed.

Related Results

RNA reprogramming of α‐mannosidase mRNA sequences in vitro by myxomycete group IC1 and IE ribozymes
RNA reprogramming of α‐mannosidase mRNA sequences in vitro by myxomycete group IC1 and IE ribozymes
Trans‐splicing group I ribozymes have been introduced in order to mediate RNA reprogramming (including RNA repair) of therapeutically relevant RNA transcripts. Efficient RNA reprog...
Mapping the Conformational Landscape of the Neutral Network of RNA Sequences That Connect Two Functional Distinctly Different Ribozymes
Mapping the Conformational Landscape of the Neutral Network of RNA Sequences That Connect Two Functional Distinctly Different Ribozymes
AbstractDuring evolution of an RNA world, the development of enzymatic function was essential. Such enzymatic function was linked to RNA sequences capable of adopting specific RNA ...
Regards sur les ribozymes
Regards sur les ribozymes
Derrière le néologisme « ribozymes » se cache une famille de molécules fascinantes, des ribo-enzymes, pourtant relativement peu étudiées. Ces ARN doués d’activité catalytique sont ...
PocketAID: The Pocket Atlas of Infectious Diseases Mobile Application
PocketAID: The Pocket Atlas of Infectious Diseases Mobile Application
ObjectiveThe Pocket Atlas of Infectious Diseases (PocketAID) mobile application developed at Pacific Northwest National Laboratory (PNNL) provides infectious disease education and ...
Development, Reliability and Validity of Infectious Disease Specialist Nurse’s Core Competence Scale
Development, Reliability and Validity of Infectious Disease Specialist Nurse’s Core Competence Scale
Abstract Aim: This study aimsto develop an instrument to measure infectious disease specialist nurses’ core competence and examining the scale’s validity and reliability.Ba...
CELL CROSS TALK IN DISEASES: THE INTERPLAY BETWEEN STEM CELLS AND SOME INFECTIOUS DISEASES, THERAPEUTIC PROSPECTS IN LOW-INCOME COUNTRIES
CELL CROSS TALK IN DISEASES: THE INTERPLAY BETWEEN STEM CELLS AND SOME INFECTIOUS DISEASES, THERAPEUTIC PROSPECTS IN LOW-INCOME COUNTRIES
Particularly in low-income nations, infectious illnesses continue to be a significant global health burden. The interaction of stem cells with infectious diseases has become a fasc...
The structure and catalytic mechanism of new cellular and viral HDV ribozymes
The structure and catalytic mechanism of new cellular and viral HDV ribozymes
ABSTRACT We have determined the molecular structure and investigated the catalytic mechanism of two new ribozymes of the Hepatitis delta virus fa...

Back to Top